Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway

Abstract Background/Aims Chemotherapy resistance in liver cancer is a major clinical issue, with CD147 playing a vital role in this process. However, the specific mechanisms underlying these processes remain largely unknown. This study investigates how CD147 internalization leads to cytoprotective a...

Full description

Saved in:
Bibliographic Details
Main Authors: Meirui Qian, Ziyu Wan, Xue Liang, Lin Jing, Huijie Zhang, Heyao Qin, Wenli Duan, Ruo Chen, Tianjiao Zhang, Qian He, Meng Lu, Jianli Jiang
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Cell Communication and Signaling
Subjects:
Online Access:https://doi.org/10.1186/s12964-024-01956-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850136568702959616
author Meirui Qian
Ziyu Wan
Xue Liang
Lin Jing
Huijie Zhang
Heyao Qin
Wenli Duan
Ruo Chen
Tianjiao Zhang
Qian He
Meng Lu
Jianli Jiang
author_facet Meirui Qian
Ziyu Wan
Xue Liang
Lin Jing
Huijie Zhang
Heyao Qin
Wenli Duan
Ruo Chen
Tianjiao Zhang
Qian He
Meng Lu
Jianli Jiang
author_sort Meirui Qian
collection DOAJ
description Abstract Background/Aims Chemotherapy resistance in liver cancer is a major clinical issue, with CD147 playing a vital role in this process. However, the specific mechanisms underlying these processes remain largely unknown. This study investigates how CD147 internalization leads to cytoprotective autophagy, contributing to chemotherapy resistance in hepatocellular carcinoma (HCC). Methods Utilizing bioinformatics methods for KEGG pathways enrichment and screening key molecules associated with chemotherapy resistance through analyses of GEO and TCGA databases. An overexpression/knockdown system was used to study how CD147 internalization leads to autophagy in vitro and in vivo. The process was observed using microscopes, and molecular interactions and autophagy flux were analyzed. Analyzing the internalization of CD147 intracellular domains and the interaction with G3BP1 in clinical chemotherapy recurrence HCC tissues by immunohistochemistry, tissue immunofluorescence, and mass spectrometry. A tumor xenograft mice model was used to study cytoprotective autophagy induced by CD147 and test the effectiveness of combining cisplatin with an autophagy inhibitor in nude mice models. Results In our study, we identified the tumor-associated membrane protein CD147, which implicated in chemoresistance lysosome pathways, by evaluating its protein degree value and betweenness centrality using Cytoscape. Our findings revealed that CD147 undergoes internalization and interacts with G3BP1 following treatment with cisplatin and methyl-β-cyclodextrin, forming a complex that is transported to lysosomes via Rab7A. Notably, higher doses of cisplatin enhanced CD147-mediated lysosomal transport while concurrently inhibiting SG assembly. The CD147-G3BP1 complex additionally inhibits mTOR activity, promoting autophagy and augmenting chemoresistance in hepatoma cells. In vivo studies investigations and analyses of clinical samples revealed that elevated internalization of CD147 is associated with chemotherapy recurrence in liver cancer and the maintenance of stem cells. Mice experiments found that the combined administration of cisplatin and hydroxychloroquine enhanced the efficacy of treatment. Conclusions This study reveals that CD147 internalization and CD147-G3BP1 complex translocation to lysosomes induce cytoprotective autophagy, reducing chemotherapy sensitivity by suppressing mTOR activity. It is also shown that chemotherapy drugs combined with autophagy inhibitors can improve the therapeutic effect of cancer, providing new insights into potential targeted therapeutic approaches in treating HCC.
format Article
id doaj-art-bace4bb2e8e54abbbe828f38d3ab49bf
institution OA Journals
issn 1478-811X
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series Cell Communication and Signaling
spelling doaj-art-bace4bb2e8e54abbbe828f38d3ab49bf2025-08-20T02:31:04ZengBMCCell Communication and Signaling1478-811X2024-12-0122112210.1186/s12964-024-01956-5Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathwayMeirui Qian0Ziyu Wan1Xue Liang2Lin Jing3Huijie Zhang4Heyao Qin5Wenli Duan6Ruo Chen7Tianjiao Zhang8Qian He9Meng Lu10Jianli Jiang11Department of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical UniversityDepartment of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical UniversityDepartment of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical UniversityDepartment of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical UniversityDepartment of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical UniversityDepartment of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical UniversitySchool of Basic Medicine, Fourth Military Medical UniversityDepartment of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical UniversityDepartment of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical UniversityDepartment of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical UniversityDepartment of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical UniversityDepartment of Cell Biology, National Translational Science Center for Molecular Medicine, Fourth Military Medical UniversityAbstract Background/Aims Chemotherapy resistance in liver cancer is a major clinical issue, with CD147 playing a vital role in this process. However, the specific mechanisms underlying these processes remain largely unknown. This study investigates how CD147 internalization leads to cytoprotective autophagy, contributing to chemotherapy resistance in hepatocellular carcinoma (HCC). Methods Utilizing bioinformatics methods for KEGG pathways enrichment and screening key molecules associated with chemotherapy resistance through analyses of GEO and TCGA databases. An overexpression/knockdown system was used to study how CD147 internalization leads to autophagy in vitro and in vivo. The process was observed using microscopes, and molecular interactions and autophagy flux were analyzed. Analyzing the internalization of CD147 intracellular domains and the interaction with G3BP1 in clinical chemotherapy recurrence HCC tissues by immunohistochemistry, tissue immunofluorescence, and mass spectrometry. A tumor xenograft mice model was used to study cytoprotective autophagy induced by CD147 and test the effectiveness of combining cisplatin with an autophagy inhibitor in nude mice models. Results In our study, we identified the tumor-associated membrane protein CD147, which implicated in chemoresistance lysosome pathways, by evaluating its protein degree value and betweenness centrality using Cytoscape. Our findings revealed that CD147 undergoes internalization and interacts with G3BP1 following treatment with cisplatin and methyl-β-cyclodextrin, forming a complex that is transported to lysosomes via Rab7A. Notably, higher doses of cisplatin enhanced CD147-mediated lysosomal transport while concurrently inhibiting SG assembly. The CD147-G3BP1 complex additionally inhibits mTOR activity, promoting autophagy and augmenting chemoresistance in hepatoma cells. In vivo studies investigations and analyses of clinical samples revealed that elevated internalization of CD147 is associated with chemotherapy recurrence in liver cancer and the maintenance of stem cells. Mice experiments found that the combined administration of cisplatin and hydroxychloroquine enhanced the efficacy of treatment. Conclusions This study reveals that CD147 internalization and CD147-G3BP1 complex translocation to lysosomes induce cytoprotective autophagy, reducing chemotherapy sensitivity by suppressing mTOR activity. It is also shown that chemotherapy drugs combined with autophagy inhibitors can improve the therapeutic effect of cancer, providing new insights into potential targeted therapeutic approaches in treating HCC.https://doi.org/10.1186/s12964-024-01956-5CD147ChemoresistanceCytoprotective autophagyG3BP1SG
spellingShingle Meirui Qian
Ziyu Wan
Xue Liang
Lin Jing
Huijie Zhang
Heyao Qin
Wenli Duan
Ruo Chen
Tianjiao Zhang
Qian He
Meng Lu
Jianli Jiang
Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway
Cell Communication and Signaling
CD147
Chemoresistance
Cytoprotective autophagy
G3BP1
SG
title Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway
title_full Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway
title_fullStr Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway
title_full_unstemmed Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway
title_short Targeting autophagy in HCC treatment: exploiting the CD147 internalization pathway
title_sort targeting autophagy in hcc treatment exploiting the cd147 internalization pathway
topic CD147
Chemoresistance
Cytoprotective autophagy
G3BP1
SG
url https://doi.org/10.1186/s12964-024-01956-5
work_keys_str_mv AT meiruiqian targetingautophagyinhcctreatmentexploitingthecd147internalizationpathway
AT ziyuwan targetingautophagyinhcctreatmentexploitingthecd147internalizationpathway
AT xueliang targetingautophagyinhcctreatmentexploitingthecd147internalizationpathway
AT linjing targetingautophagyinhcctreatmentexploitingthecd147internalizationpathway
AT huijiezhang targetingautophagyinhcctreatmentexploitingthecd147internalizationpathway
AT heyaoqin targetingautophagyinhcctreatmentexploitingthecd147internalizationpathway
AT wenliduan targetingautophagyinhcctreatmentexploitingthecd147internalizationpathway
AT ruochen targetingautophagyinhcctreatmentexploitingthecd147internalizationpathway
AT tianjiaozhang targetingautophagyinhcctreatmentexploitingthecd147internalizationpathway
AT qianhe targetingautophagyinhcctreatmentexploitingthecd147internalizationpathway
AT menglu targetingautophagyinhcctreatmentexploitingthecd147internalizationpathway
AT jianlijiang targetingautophagyinhcctreatmentexploitingthecd147internalizationpathway